Literature DB >> 8034776

Type I collagen carboxyterminal telopeptide in human gingival crevicular fluid in different clinical conditions and after periodontal treatment.

J T Talonpoika1, M M Hämäläinen.   

Abstract

A total of 126 gingival crevicular fluid (GCF) samples were collected from 20 adults using paper strips. Patients were divided into a periodontitis-affected group (13 subjects) and a periodontitis-free group (7 subjects) by pocket depth and radiological bone loss. 4 subjects from the periodontitis-affected group received a single episode of periodontal treatment (scaling, root planing and curettage) and GCF samples were collected 2, 5, 10, 20 and 40 days after treatment. Type I collagen carboxyterminal telopeptide (ICTP) in GCF was extracted into saline solution and determined by a radioimmunological method. Mean GCF ICTP concentration was 425 micrograms/l (SEM 45) in periodontitis patients and 148 micrograms/l (SEM 25) in periodontitis-free subjects, i.e., GCF ICTP concentrations were about 100 x higher than serum reference values. Significant positive correlations were found between GCF ICTP total amount per site and plaque index (R = 0.362), papilla bleeding index (R = 0.259), pocket depth (R = 0.464) and radiological bone loss (R = 0.418). Periodontal treatment decreased GCF ICTP concentration to the level seen in healthy subjects. However, large variations were seen between subjects and sites. ICTP levels below the detection limit were often found in deep pockets, as well as high values in periodontitis-free subjects. It was concluded that GCF ICTP reflects the local type I collagen degradation in periodontal tissues, and probably gives information about the tissue destruction process beyond the reach of the clinical parameters.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8034776     DOI: 10.1111/j.1600-051x.1994.tb00720.x

Source DB:  PubMed          Journal:  J Clin Periodontol        ISSN: 0303-6979            Impact factor:   8.728


  13 in total

Review 1.  Diagnostic biomarkers for oral and periodontal diseases.

Authors:  Mario Taba; Janet Kinney; Amy S Kim; William V Giannobile
Journal:  Dent Clin North Am       Date:  2005-07

2.  Relationship between C-telopeptide pyridinoline cross-links (ICTP) and putative periodontal pathogens in periodontitis.

Authors:  M D Palys; A D Haffajee; S S Socransky; W V Giannobile
Journal:  J Clin Periodontol       Date:  1998-11       Impact factor: 8.728

3.  C-telopeptide pyridinoline cross-links (ICTP) and periodontal pathogens associated with endosseous oral implants.

Authors:  R J Oringer; M D Palys; A Iranmanesh; J P Fiorellini; A D Haffajee; S S Socransky; W V Giannobile
Journal:  Clin Oral Implants Res       Date:  1998-12       Impact factor: 5.977

Review 4.  Oral fluid-based biomarkers of alveolar bone loss in periodontitis.

Authors:  Janet S Kinney; Christoph A Ramseier; William V Giannobile
Journal:  Ann N Y Acad Sci       Date:  2007-03       Impact factor: 5.691

Review 5.  C-telopeptide pyridinoline cross-links. Sensitive indicators of periodontal tissue destruction.

Authors:  W V Giannobile
Journal:  Ann N Y Acad Sci       Date:  1999-06-30       Impact factor: 5.691

6.  Candidate salivary biomarkers associated with alveolar bone loss: cross-sectional and in vitro studies.

Authors:  Patricia Yen Bee Ng; Maureen Donley; Ernest Hausmann; Alan D Hutson; Edward F Rossomando; Frank A Scannapieco
Journal:  FEMS Immunol Med Microbiol       Date:  2007-03

7.  Effect of rhPDGF-BB on bone turnover during periodontal repair.

Authors:  David P Sarment; Jason W Cooke; Sarah E Miller; Qiming Jin; Michael K McGuire; Richard T Kao; Pamela K McClain; Bradley S McAllister; Samuel E Lynch; William V Giannobile
Journal:  J Clin Periodontol       Date:  2006-02       Impact factor: 8.728

8.  Effect of rhPDGF-BB delivery on mediators of periodontal wound repair.

Authors:  Jason W Cooke; David P Sarment; Louis A Whitesman; Sarah E Miller; Qiming Jin; Samuel E Lynch; William V Giannobile
Journal:  Tissue Eng       Date:  2006-06

9.  Saliva as a diagnostic tool for periodontal disease: current state and future directions.

Authors:  William V Giannobile; Thomas Beikler; Janet S Kinney; Christoph A Ramseier; Thiago Morelli; David T Wong
Journal:  Periodontol 2000       Date:  2009       Impact factor: 7.589

10.  Effect of gingival application of melatonin on alkaline and acid phosphatase, osteopontin and osteocalcin in patients with diabetes and periodontal disease.

Authors:  Antonio Cutando; Antonio López-Valverde; Rafel Gómez-de-Diego; Salvador Arias-Santiago; Joaquín de Vicente-Jiménez
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2013-07-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.